Filing Details
- Accession Number:
- 0001093557-20-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-07 20:50:17
- Reporting Period:
- 2020-01-03
- Accepted Time:
- 2020-01-07 20:50:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236386 | S Jay Skyler | 6340 Sequence Drive San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-01-03 | 2,700 | $216.16 | 53,523 | No | 4 | S | Indirect | by Partnership |
| Common Stock | Disposition | 2020-01-03 | 5,564 | $217.31 | 47,959 | No | 4 | S | Indirect | by Partnership |
| Common Stock | Disposition | 2020-01-03 | 14,456 | $218.14 | 33,503 | No | 4 | S | Indirect | by Partnership |
| Common Stock | Disposition | 2020-01-03 | 3,086 | $218.94 | 30,417 | No | 4 | S | Indirect | by Partnership |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | by Partnership |
| No | 4 | S | Indirect | by Partnership |
| No | 4 | S | Indirect | by Partnership |
| No | 4 | S | Indirect | by Partnership |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,729 | Direct | |
| Common Stock | 10,000 | Indirect | by Spouse |
Footnotes
- On August 6, 2019, Mr. Skyler adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Skyler. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- This transaction was executed in multiple trades at prices ranging from $215.59 to $216.53. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $216.66 to $217.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $217.66 to $218.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $218.66 to $219.29. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
